These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8951981)

  • 41. Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo.
    Williams MB; Jope RS
    Neuroreport; 1994 May; 5(9):1118-20. PubMed ID: 8080969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.
    Darmani NA; Mock OB; Towns LC; Gerdes CF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):383-96. PubMed ID: 8090805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.
    Ponzoni L; Braida D; Sala M
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3031-9. PubMed ID: 27318987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between 5-hydroxytryptamine (5-HT) and testosterone in the control of sexual and nonsexual behaviour in male and female rats.
    Gonzalez MI; Farabollini F; Albonetti E; Wilson CA
    Pharmacol Biochem Behav; 1994 Mar; 47(3):591-601. PubMed ID: 8208779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats.
    Wada Y; Shiraishi J; Nakamura M; Koshino Y
    Brain Res; 1997 Feb; 747(2):338-42. PubMed ID: 9046012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
    Ferry RC; Unsworth CD; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ritanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons.
    Shi WX; Nathaniel P; Bunney BS
    J Pharmacol Exp Ther; 1995 Aug; 274(2):735-40. PubMed ID: 7636736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
    Wang S; Zhang QJ; Liu J; Ali U; Wu ZH; Chen L; Gui ZH; Wang Y; Hui YP
    Exp Neurol; 2009 Sep; 219(1):239-48. PubMed ID: 19500571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the serotonin2 receptor agonist DOI on skeletal muscle specimens from malignant hyperthermia-susceptible patients.
    Wappler F; Roewer N; Köchling A; Scholz J; Löscher W; Steinfath M
    Anesthesiology; 1996 Jun; 84(6):1280-7. PubMed ID: 8669667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum.
    Body S; Asgari K; Cheung TH; Bezzina G; Fone KF; Glennon JC; Bradshaw CM; Szabadi E
    Behav Processes; 2006 Feb; 71(2-3):258-67. PubMed ID: 16326032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment.
    Kaur P; Ahlenius S
    J Neural Transm (Vienna); 1997; 104(6-7):605-14. PubMed ID: 9444561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.
    Filip M; Bubar MJ; Cunningham KA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1246-54. PubMed ID: 15131246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat.
    Danuser H; Thor KB
    Br J Pharmacol; 1996 May; 118(1):150-4. PubMed ID: 8733588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of synapse density by 5-HT2A receptor agonist and antagonist in the spinal cord of chicken embryo.
    Niitsu Y; Hamada S; Hamaguchi K; Mikuni M; Okado N
    Neurosci Lett; 1995 Aug; 195(3):159-62. PubMed ID: 8584199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
    Darmani NA; Martin BR; Glennon RA
    Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeated cocaine modifies the neuroendocrine responses to the 5-HT1C/5-HT2 receptor agonist DOI.
    Levy AD; Li Q; Alvarez Sanz MC; Rittenhouse PA; Brownfield MS; Van de Kar LD
    Eur J Pharmacol; 1992 Oct; 221(1):121-7. PubMed ID: 1333968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.